TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs17615250
log Bayes Factor = 142.837
Chromosome 6   position 32,678,973  (GRCh37) Explore rs17615250 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
0.000 0.000 1.000
E10.3 With ophthalmic complications
0.000 0.000 1.000
E10.1 With ketoacidosis
0.000 0.000 1.000
J45.9 Asthma, unspecified
1.000 0.000 0.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
G35 Multiple sclerosis
0.000 0.000 1.000
N48 Other disorders of penis
1.000 0.000 0.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
H36.0 Diabetic retinopathy
0.000 0.000 1.000
E16.2 Hypoglycaemia, unspecified
0.000 0.000 1.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E10.4 With neurological complications
0.000 0.000 1.000
E16 Other disorders of pancreatic internal secretion
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
N47 Redundant prepuce, phimosis and paraphimosis
0.999 0.001 0.000
N48.6 Balanitis xerotica obliterans
0.999 0.001 0.000
E03.9 Hypothyroidism, unspecified
0.999 0.001 0.000
E14 Unspecified diabetes mellitus
0.000 0.001 0.999
E10.2 With renal complications
0.000 0.002 0.998
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.002 0.998
E14.3 With ophthalmic complications
0.000 0.003 0.997
N48.1 Balanoposthitis
0.996 0.004 0.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.007 0.993
E10.5 With peripheral circulatory complications
0.000 0.007 0.993
N40-N51 Diseases of male genital organs
0.989 0.011 0.000
M35.3 Polymyalgia rheumatica
0.000 0.017 0.983
M35.0 Sicca syndrome [Sjogren]
0.000 0.017 0.983
M35 Other systemic involvement of connective tissue
0.000 0.019 0.981
N48.0 Leukoplakia of penis
0.976 0.024 0.000
L40 Psoriasis
0.961 0.039 0.000
E50-E64 Other nutritional deficiencies
0.000 0.061 0.939
D07.1 Vulva
0.928 0.072 0.000
E55 Vitamin D deficiency
0.000 0.085 0.915
L40.0 Psoriasis vulgaris
0.912 0.088 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.912 0.088 0.000
N48.8 Other specified disorders of penis
0.907 0.093 0.000
D00-D09 In situ neoplasms
0.899 0.101 0.000
E55.9 Vitamin D deficiency, unspecified
0.000 0.101 0.899
N48.2 Other inflammatory disorders of penis
0.891 0.109 0.000
D06 Carcinoma in situ of cervix uteri
0.884 0.116 0.000
D06.9 Cervix, unspecified
0.867 0.133 0.000
E10.0 With coma
0.000 0.135 0.865
N48.5 Ulcer of penis
0.859 0.141 0.000
E06 Thyroiditis
0.000 0.145 0.855
L90.0 Lichen sclerosus et atrophicus
0.854 0.146 0.000
N44 Torsion of testis
0.844 0.155 0.000
C21.1 Anal canal
0.833 0.167 0.000
C21 Malignant neoplasm of anus and anal canal
0.827 0.173 0.000
C21.0 Anus, unspecified
0.827 0.173 0.000
N48.9 Disorder of penis, unspecified
0.823 0.177 0.000
D07.4 Penis
0.821 0.179 0.000
E03 Other hypothyroidism
0.646 0.192 0.162
E14.6 With other specified complications
0.000 0.195 0.805
E10.8 With unspecified complications
0.000 0.200 0.800
M35.1 Other overlap syndromes
0.000 0.200 0.800
D04 Carcinoma in situ of skin
0.797 0.203 0.000
L40.8 Other psoriasis
0.789 0.211 0.000
E40-E46 Malnutrition
0.000 0.211 0.789
E14.8 With unspecified complications
0.000 0.216 0.784
N42 Other disorders of prostate
0.782 0.218 0.000
D09 Carcinoma in situ of other and unspecified sites
0.780 0.220 0.000
E14.9 Without complications
0.000 0.222 0.778
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.224 0.776
M35.2 Behcet's disease
0.000 0.225 0.775
L40.4 Guttate psoriasis
0.773 0.227 0.000
E07 Other disorders of thyroid
0.000 0.229 0.771
N48.4 Impotence of organic origin
0.771 0.229 0.000
E14.5 With peripheral circulatory complications
0.000 0.234 0.766
N45 Orchitis and epididymitis
0.763 0.237 0.000
L90 Atrophic disorders of skin
0.761 0.239 0.000
E10.6 With other specified complications
0.000 0.249 0.751
D01 Carcinoma in situ of other and unspecified digestive organs
0.750 0.250 0.000
D03 Melanoma in situ
0.743 0.257 0.000
D04.7 Skin of lower limb, including hip
0.742 0.258 0.000
L90.5 Scar conditions and fibrosis of skin
0.741 0.259 0.000
L40.1 Generalised pustular psoriasis
0.740 0.260 0.000
N48.3 Priapism
0.734 0.266 0.000
E06.9 Thyroiditis, unspecified
0.000 0.271 0.729
E51 Thiamine deficiency
0.000 0.272 0.728
E14.2 Withrenal complications
0.000 0.274 0.726
D04.9 Skin, unspecified
0.721 0.278 0.000
L40.5 Arthropathic psoriasis
0.719 0.281 0.000
E10.7 With multiple complications
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E15 Nondiabetic hypoglycaemic coma
0.000 0.283 0.717
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.283 0.717
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.283 0.717
E16.4 Abnormal secretion of gastrin
0.000 0.283 0.717
E16.3 Increased secretion of glucagon
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E14.7 With multiple complications
0.000 0.284 0.716
E14.0 With coma
0.000 0.284 0.716
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.290 0.710
M35.9 Systemic involvement of connective tissue, unspecified
0.000 0.296 0.703
M35.6 Relapsing panniculitis [Weber-Christian]
0.000 0.296 0.703
M35.5 Multifocal fibrosclerosis
0.000 0.296 0.703
M35.4 Diffuse (eosinophilic) fasciitis
0.000 0.296 0.703
D06.1 Exocervix
0.699 0.301 0.000
N51 Disorders of male genital organs in diseases classified elsewhere
0.699 0.301 0.000
C21.8 Overlapping lesion of rectum, anus and anal canal
0.696 0.304 0.000
D09.1 Other and unspecified urinary organs
0.689 0.311 0.000
L40.2 Acrodermatitis continua
0.689 0.311 0.000
M35.7 Hypermobility syndrome
0.000 0.312 0.688
L40.3 Pustulosis palmaris et plantaris
0.683 0.317 0.000
E06.3 Autoimmune thyroiditis
0.000 0.322 0.678
E14.1 With ketoacidosis
0.000 0.322 0.678
D03.2 Melanoma in situ of ear and external auricular canal
0.676 0.324 0.000
D06.0 Endocervix
0.675 0.325 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.327 0.673
E63 Other nutritional deficiencies
0.000 0.327 0.673
E50 Vitamin A deficiency
0.000 0.327 0.673
E60 Dietary zinc deficiency
0.000 0.327 0.673
E59 Dietary selenium deficiency
0.000 0.327 0.673
E54 Ascorbic acid deficiency
0.000 0.327 0.673
E52 Niacin deficiency [pellagra]
0.000 0.327 0.673
E07.8 Other specified disorders of thyroid
0.000 0.333 0.667
D02 Carcinoma in situ of middle ear and respiratory system
0.666 0.334 0.000
E05.8 Other thyrotoxicosis
0.000 0.342 0.658
D01.3 Anus and anal canal
0.658 0.342 0.000
E55.0 Rickets, active
0.000 0.344 0.656
D07.6 Other and unspecified male genital organs
0.654 0.346 0.000
D07.3 Other and unspecified female genital organs
0.654 0.346 0.000
D07.0 Endometrium
0.654 0.346 0.000
D09.7 Carcinoma in situ of other specified sites
0.641 0.359 0.000
N42.9 Disorder of prostate, unspecified
0.640 0.360 0.000
E53 Deficiency of other B group vitamins
0.000 0.363 0.637
E46 Unspecified protein-energy malnutrition
0.000 0.363 0.637
D07.2 Vagina
0.636 0.364 0.000
D04.3 Skin of other and unspecified parts of face
0.635 0.365 0.000
D06.7 Other parts of cervix
0.634 0.366 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.633 0.367 0.000
D04.4 Skin of scalp and neck
0.622 0.377 0.000
M35.8 Other specified systemic involvement of connective tissue
0.000 0.380 0.619
N42.1 Congestion and haemorrhage of prostate
0.617 0.383 0.000
E14.4 With neurological complications
0.000 0.386 0.614
E58 Dietary calcium deficiency
0.000 0.386 0.613
E06.4 Drug-induced thyroiditis
0.000 0.387 0.613
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.387 0.613
E06.1 Subacute thyroiditis
0.000 0.387 0.613
E06.0 Acute thyroiditis
0.000 0.387 0.613
N42.3 Dysplasia of prostate
0.613 0.387 0.000
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.610 0.390 0.000
D03.6 Melanoma in situ of upper limb, including shoulder
0.609 0.391 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.498 0.400 0.103
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.508 0.403 0.089
C21.2 Cloacogenic zone
0.593 0.407 0.000
E56 Other vitamin deficiencies
0.000 0.408 0.592
D03.5 Melanoma in situ of trunk
0.590 0.410 0.000
E61 Deficiency of other nutrient elements
0.000 0.410 0.590
D03.8 Melanoma in situ of other sites
0.589 0.411 0.000
E06.5 Other chronic thyroiditis
0.000 0.417 0.583
G35-G37 Demyelinating diseases of the central nervous system
0.000 0.419 0.581
E03.5 Myxoedema coma
0.463 0.421 0.116
E03.4 Atrophy of thyroid (acquired)
0.463 0.421 0.116
E03.3 Postinfectious hypothyroidism
0.463 0.421 0.116
E51.2 Wernicke's encephalopathy
0.000 0.422 0.578
N42.8 Other specified disorders of prostate
0.576 0.424 0.000
D04.8 Skin of other sites
0.571 0.428 0.000
D04.0 Skin of lip
0.571 0.428 0.000
E03.1 Congenital hypothyroidism without goitre
0.454 0.432 0.114
N42.2 Atrophy of prostate
0.567 0.433 0.000
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.434 0.565
E45 Retarded development following protein-energy malnutrition
0.000 0.434 0.565
E43 Unspecified severe protein-energy malnutrition
0.000 0.434 0.565
E42 Marasmic kwashiorkor
0.000 0.434 0.565
E41 Nutritional marasmus
0.000 0.434 0.565
E40 Kwashiorkor
0.000 0.434 0.565
D09.9 Carcinoma in situ, unspecified
0.560 0.440 0.000
D09.3 Thyroid and other endocrine glands
0.560 0.440 0.000
D09.2 Eye
0.560 0.440 0.000
E04 Other non-toxic goitre
0.000 0.447 0.553
E07.1 Dyshormogenetic goitre
0.000 0.447 0.553
E07.0 Hypersecretion of calcitonin
0.000 0.447 0.553
N49 Inflammatory disorders of male genital organs, not elsewhere classified
0.551 0.449 0.000
L90.8 Other atrophic disorders of skin
0.551 0.449 0.000
L90.9 Atrophic disorder of skin, unspecified
0.545 0.455 0.000
L90.6 Striae atrophicae
0.545 0.455 0.000
L90.4 Acrodermatitis chronica atrophicans
0.545 0.455 0.000
L90.3 Atrophoderma of Pasini and Pierini
0.545 0.455 0.000
L90.2 Anetoderma of Jadassohn-Pellizzari
0.545 0.455 0.000
L90.1 Anetoderma of Schweninger-Buzzi
0.545 0.455 0.000
D01.9 Digestive organ, unspecified
0.538 0.462 0.000
D01.7 Other specified digestive organs
0.538 0.462 0.000
D01.5 Liver, gallbladder and bile ducts
0.538 0.462 0.000
D01.4 Other and unspecified parts of intestine
0.538 0.462 0.000
D01.2 Rectum
0.538 0.462 0.000
D01.1 Rectosigmoid junction
0.538 0.462 0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess
0.536 0.464 0.000
D03.9 Melanoma in situ, unspecified
0.533 0.467 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.533 0.467 0.000
D03.0 Melanoma in situ of lip
0.533 0.467 0.000
D04.1 Skin of eyelid, including canthus
0.532 0.468 0.000
E03.8 Other specified hypothyroidism
0.433 0.468 0.098
E51.9 Thiamine deficiency, unspecified
0.000 0.478 0.522
E51.8 Other manifestations of thiamine deficiency
0.000 0.478 0.522
E51.1 Beriberi
0.000 0.478 0.522
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.483 0.517
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E16.1 Other hypoglycaemia
0.000 0.486 0.514
E53.9 Vitamin B deficiency, unspecified
0.000 0.488 0.512
D01.0 Colon
0.507 0.493 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.506 0.493 0.000
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified
0.000 0.495 0.504
E04.0 Non-toxic diffuse goitre
0.000 0.499 0.501
N51.8 Other disorders of male genital organs in diseases classified elsewhere
0.501 0.499 0.000
N51.1 Disorders of testis and epididymis in diseases classified elsewhere
0.501 0.499 0.000
N51.0 Disorders of prostate in diseases classified elsewhere
0.501 0.499 0.000
E20-E35 Disorders of other endocrine glands
0.000 0.500 0.500
G37 Other demyelinating diseases of central nervous system
0.000 0.504 0.496
D02.0 Larynx
0.491 0.509 0.000
N51.2 Balanitis in diseases classified elsewhere
0.491 0.509 0.000
K90 Intestinal malabsorption
0.000 0.510 0.490
D02.2 Bronchus and lung
0.486 0.514 0.000
E50.9 Vitamin A deficiency, unspecified
0.000 0.517 0.482
E50.8 Other manifestations of vitamin A deficiency
0.000 0.517 0.482
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.517 0.482
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.517 0.482
E50.5 Vitamin A deficiency with night blindness
0.000 0.517 0.482
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.517 0.482
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.517 0.482
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.517 0.482
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.517 0.482
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.517 0.482
E63.9 Nutritional deficiency, unspecified
0.000 0.517 0.482
E63.8 Other specified nutritional deficiencies
0.000 0.517 0.482
E63.1 Imbalance of constituents of food intake
0.000 0.517 0.482
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.517 0.482
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.517 0.482
E64.8 Sequelae of other nutritional deficiencies
0.000 0.517 0.482
E64.3 Sequelae of rickets
0.000 0.517 0.482
E64.2 Sequelae of vitamin C deficiency
0.000 0.517 0.482
E64.1 Sequelae of vitamin A deficiency
0.000 0.517 0.482
E64.0 Sequelae of protein-energy malnutrition
0.000 0.517 0.482
N41 Inflammatory diseases of prostate
0.481 0.519 0.000
D02.4 Respiratory system, unspecified
0.477 0.522 0.000
D02.3 Other parts of respiratory system
0.477 0.522 0.000
D02.1 Trachea
0.477 0.522 0.000
L40-L45 Papulosquamous disorders
0.476 0.524 0.000
N46 Male infertility
0.465 0.534 0.001
E13 Other specified diabetes mellitus
0.001 0.535 0.465
D00.0 Lip, oral cavity and pharynx
0.464 0.536 0.000
E27 Other disorders of adrenal gland
0.000 0.543 0.457
E53.1 Pyridoxine deficiency
0.000 0.543 0.457
E53.0 Riboflavin deficiency
0.000 0.543 0.457
D09.0 Bladder
0.455 0.545 0.000
D00.2 Stomach
0.454 0.546 0.000
H36 Retinal disorders in diseases classified elsewhere
0.000 0.546 0.454
E27.1 Primary adrenocortical insufficiency
0.000 0.549 0.451
E61.2 Magnesium deficiency
0.000 0.550 0.450
E34 Other endocrine disorders
0.000 0.558 0.442
E65-E68 Obesity and other hyperalimentation
0.000 0.561 0.439
D00.1 Oesophagus
0.432 0.568 0.000
D04.5 Skin of trunk
0.431 0.569 0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.000 0.571 0.429
E07.9 Disorder of thyroid, unspecified
0.000 0.571 0.429
E56.9 Vitamin deficiency, unspecified
0.000 0.575 0.425
E56.8 Deficiency of other vitamins
0.000 0.575 0.425
E56.0 Deficiency of vitamin E
0.000 0.575 0.425
E61.9 Deficiency of nutrient element, unspecified
0.000 0.577 0.423
E61.8 Deficiency of other specified nutrient elements
0.000 0.577 0.423
E61.7 Deficiency of multiple nutrient elements
0.000 0.577 0.423
E61.6 Vanadium deficiency
0.000 0.577 0.423
E61.5 Molybdenum deficiency
0.000 0.577 0.423
E61.4 Chromium deficiency
0.000 0.577 0.423
E61.3 Manganese deficiency
0.000 0.577 0.423
E61.0 Copper deficiency
0.000 0.577 0.423
G36 Other acute disseminated demyelination
0.000 0.583 0.417
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens
0.407 0.593 0.000
E44.1 Mild protein-energy malnutrition
0.000 0.594 0.405
E44.0 Moderate protein-energy malnutrition
0.000 0.594 0.405
N30.2 Other chronic cystitis
0.398 0.602 0.000
L42 Pityriasis rosea
0.398 0.602 0.000
E04.8 Other specified non-toxic goitre
0.000 0.603 0.397
N49.9 Inflammatory disorder of unspecified male genital organ
0.395 0.605 0.000
N49.0 Inflammatory disorders of seminal vesicle
0.395 0.605 0.000
G37.9 Demyelinating disease of central nervous system, unspecified
0.000 0.607 0.393
N43 Hydrocele and spermatocele
0.393 0.607 0.000
D04.2 Skin of ear and external auricular canal
0.390 0.610 0.000
E04.2 Non-toxic multinodular goitre
0.000 0.616 0.384
L44 Other papulosquamous disorders
0.383 0.617 0.000
D03.4 Melanoma in situ of scalp and neck
0.380 0.620 0.000
E27.8 Other specified disorders of adrenal gland
0.000 0.621 0.379
E34.0 Carcinoid syndrome
0.000 0.623 0.377
N30 Cystitis
0.374 0.626 0.000
E28 Ovarian dysfunction
0.000 0.629 0.371
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.635 0.365
K90.9 Intestinal malabsorption, unspecified
0.000 0.638 0.362
N41.0 Acute prostatitis
0.360 0.640 0.000
E26 Hyperaldosteronism
0.000 0.640 0.360
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.641 0.359
E32 Diseases of thymus
0.000 0.641 0.359
E31 Polyglandular dysfunction
0.000 0.641 0.359
E30 Disorders of puberty, not elsewhere classified
0.000 0.641 0.359
G37.5 Concentric sclerosis [Balo]
0.000 0.644 0.356
G37.4 Subacute necrotising myelitis
0.000 0.644 0.356
G37.2 Central pontine myelinolysis
0.000 0.644 0.356
G37.1 Central demyelination of corpus callosum
0.000 0.644 0.356
G37.0 Diffuse sclerosis
0.000 0.644 0.356
K90.3 Pancreatic steatorrhoea
0.000 0.648 0.352
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.648 0.352
K90.1 Tropical sprue
0.000 0.648 0.352
N30.0 Acute cystitis
0.348 0.652 0.000
E34.9 Endocrine disorder, unspecified
0.000 0.652 0.348
J45 Asthma
0.347 0.653 0.000
N30.1 Interstitial cystitis (chronic)
0.347 0.653 0.000
K90.8 Other intestinal malabsorption
0.000 0.653 0.347
N41.3 Prostatocystitis
0.345 0.655 0.000
N41.2 Abscess of prostate
0.345 0.655 0.000
E56.1 Deficiency of vitamin K
0.001 0.656 0.344
L41 Parapsoriasis
0.341 0.659 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.341 0.659 0.000
N49.8 Inflammatory disorders of other specified male genital organs
0.341 0.659 0.000
E29 Testicular dysfunction
0.000 0.660 0.340
E34.8 Other specified endocrine disorders
0.000 0.662 0.338
D04.6 Skin of upper limb, including shoulder
0.336 0.664 0.000
E13.8 With unspecified complications
0.001 0.666 0.333
E13.7 With multiple complications
0.001 0.666 0.333
E13.6 With other specified complications
0.001 0.666 0.333
E13.5 With peripheral circulatory complications
0.001 0.666 0.333
E13.4 With neurological complications
0.001 0.666 0.333
E13.2 With renal complications
0.001 0.666 0.333
E13.1 With ketoacidosis
0.001 0.666 0.333
E13.0 With coma
0.001 0.666 0.333
E22 Hyperfunction of pituitary gland
0.000 0.667 0.333
N41.1 Chronic prostatitis
0.329 0.671 0.000
E27.5 Adrenomedullary hyperfunction
0.000 0.672 0.328
E27.0 Other adrenocortical overactivity
0.000 0.672 0.328
N42.0 Calculus of prostate
0.327 0.672 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.674 0.326
H36.8 Other retinal disorders in diseases classified elsewhere
0.000 0.674 0.325
E23 Hypofunction and other disorders of pituitary gland
0.000 0.675 0.325
G37.8 Other specified demyelinating diseases of central nervous system
0.000 0.677 0.323
E20 Hypoparathyroidism
0.000 0.678 0.322
N30.3 Trigonitis
0.318 0.682 0.000
E13.3 With ophthalmic complications
0.001 0.683 0.317
E34.5 Androgen resistance syndrome
0.000 0.683 0.317
E34.4 Constitutional tall stature
0.000 0.683 0.317
E34.3 Short stature, not elsewhere classified
0.000 0.683 0.317
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.683 0.317
E34.1 Other hypersecretion of intestinal hormones
0.000 0.683 0.317
N41.8 Other inflammatory diseases of prostate
0.317 0.683 0.000
L44.0 Pityriasis rubra pilaris
0.316 0.684 0.000
E67 Other hyperalimentation
0.000 0.685 0.315
E68 Sequelae of hyperalimentation
0.000 0.685 0.315
N43.2 Other hydrocele
0.303 0.696 0.000
N30.4 Irradiation cystitis
0.303 0.697 0.000
E25 Adrenogenital disorders
0.000 0.697 0.303
E65 Localised adiposity
0.000 0.699 0.300
E11 Non-insulin-dependent diabetes mellitus
0.000 0.700 0.300
G36.9 Acute disseminated demyelination, unspecified
0.000 0.701 0.299
G36.8 Other specified acute disseminated demyelination
0.000 0.701 0.299
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.000 0.701 0.299
G36.0 Neuromyelitis optica [Devic]
0.000 0.701 0.299
N49.2 Inflammatory disorders of scrotum
0.298 0.702 0.000
N43.1 Infected hydrocele
0.295 0.705 0.000
N90 Other noninflammatory disorders of vulva and perineum
0.294 0.706 0.000
D07.5 Prostate
0.291 0.708 0.000
E61.1 Iron deficiency
0.000 0.709 0.291
N90.7 Vulvar cyst
0.290 0.710 0.000
N90.4 Leukoplakia of vulva
0.288 0.712 0.000
N43.0 Encysted hydrocele
0.282 0.718 0.000
E28.2 Polycystic ovarian syndrome
0.000 0.718 0.282
E22.1 Hyperprolactinaemia
0.000 0.725 0.275
L44.9 Papulosquamous disorder, unspecified
0.274 0.725 0.000
L44.8 Other specified papulosquamous disorders
0.274 0.725 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.274 0.725 0.000
L44.3 Lichen ruber moniliformis
0.274 0.725 0.000
L44.2 Lichen striatus
0.274 0.725 0.000
L44.1 Lichen nitidus
0.274 0.725 0.000
N30.8 Other cystitis
0.274 0.726 0.000
N90.3 Dysplasia of vulva, unspecified
0.272 0.728 0.000
E11.3 With ophthalmic complications
0.000 0.730 0.270
N90.9 Noninflammatory disorder of vulva and perineum, unspecified
0.270 0.730 0.000
E28.9 Ovarian dysfunction, unspecified
0.000 0.734 0.266
E28.8 Other ovarian dysfunction
0.000 0.734 0.266
E28.1 Androgen excess
0.000 0.734 0.266
E28.0 Oestrogen excess
0.000 0.734 0.266
E27.9 Disorder of adrenal gland, unspecified
0.000 0.736 0.264
E04.9 Non-toxic goitre, unspecified
0.000 0.738 0.262
E28.3 Primary ovarian failure
0.000 0.739 0.261
N90.1 Moderate vulvar dysplasia
0.260 0.740 0.000
E26.0 Primary hyperaldosteronism
0.000 0.741 0.259
E26.9 Hyperaldosteronism, unspecified
0.000 0.742 0.258
E26.8 Other hyperaldosteronism
0.000 0.742 0.258
E26.1 Secondary hyperaldosteronism
0.000 0.742 0.258
E23.7 Disorder of pituitary gland, unspecified
0.000 0.742 0.258
E30.9 Disorder of puberty, unspecified
0.000 0.743 0.257
E30.8 Other disorders of puberty
0.000 0.743 0.257
E30.1 Precocious puberty
0.000 0.743 0.257
E30.0 Delayed puberty
0.000 0.743 0.257
E31.9 Polyglandular dysfunction, unspecified
0.000 0.743 0.257
E31.8 Other polyglandular dysfunction
0.000 0.743 0.257
E31.1 Polyglandular hyperfunction
0.000 0.743 0.257
E31.0 Autoimmune polyglandular failure
0.000 0.743 0.257
E32.9 Disease of thymus, unspecified
0.000 0.743 0.257
E32.8 Other diseases of thymus
0.000 0.743 0.257
E32.1 Abscess of thymus
0.000 0.743 0.257
E32.0 Persistent hyperplasia of thymus
0.000 0.743 0.257
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.743 0.257
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.743 0.257
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.743 0.257
J45.8 Mixed asthma
0.253 0.747 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.748 0.251
J45.1 Nonallergic asthma
0.249 0.751 0.000
N90.0 Mild vulvar dysplasia
0.245 0.754 0.000
L41.9 Parapsoriasis, unspecified
0.245 0.755 0.000
L41.8 Other parapsoriasis
0.245 0.755 0.000
L41.5 Retiform parapsoriasis
0.245 0.755 0.000
L41.4 Large plaque parapsoriasis
0.245 0.755 0.000
L41.3 Small plaque parapsoriasis
0.245 0.755 0.000
L41.2 Lymphomatoid papulosis
0.245 0.755 0.000
L41.1 Pityriasis lichenoides chronica
0.245 0.755 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.245 0.755 0.000
E29.8 Other testicular dysfunction
0.000 0.756 0.244
E29.0 Testicular hyperfunction
0.000 0.756 0.244
E29.1 Testicular hypofunction
0.000 0.757 0.243
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.761 0.239
E22.8 Other hyperfunction of pituitary gland
0.000 0.761 0.239
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.762 0.238
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.767 0.233
E23.1 Drug-induced hypopituitarism
0.000 0.767 0.233
E27.2 Addisonian crisis
0.000 0.767 0.233
E20.8 Other hypoparathyroidism
0.000 0.769 0.231
E20.1 Pseudohypoparathyroidism
0.000 0.769 0.231
E20.0 Idiopathic hypoparathyroidism
0.000 0.769 0.231
L43 Lichen planus
0.230 0.770 0.000
E22.0 Acromegaly and pituitary gigantism
0.000 0.773 0.227
E29.9 Testicular dysfunction, unspecified
0.000 0.773 0.226
E67.8 Other specified hyperalimentation
0.000 0.774 0.226
E67.3 Hypervitaminosis D
0.000 0.774 0.226
E67.2 Megavitamin-B6 syndrome
0.000 0.774 0.226
E67.1 Hypercarotenaemia
0.000 0.774 0.226
E67.0 Hypervitaminosis A
0.000 0.774 0.226
E23.6 Other disorders of pituitary gland
0.000 0.774 0.225
E11.8 With unspecified complications
0.000 0.778 0.221
E11.0 With coma
0.000 0.780 0.220
E25.9 Adrenogenital disorder, unspecified
0.000 0.783 0.217
E25.8 Other adrenogenital disorders
0.000 0.783 0.217
E11.7 With multiple complications
0.000 0.785 0.215
E23.0 Hypopituitarism
0.000 0.785 0.215
D03.3 Melanoma in situ of other and unspecified parts of face
0.212 0.788 0.000
N90.2 Severe vulvar dysplasia, not elsewhere classified
0.211 0.789 0.000
J45.0 Predominantly allergic asthma
0.209 0.791 0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum
0.205 0.795 0.000
E11.5 With peripheral circulatory complications
0.000 0.799 0.201
E20.9 Hypoparathyroidism, unspecified
0.000 0.805 0.195
E23.2 Diabetes insipidus
0.000 0.807 0.193
N43.4 Spermatocele
0.191 0.808 0.001
D05 Carcinoma in situ of breast
0.184 0.816 0.000
E11.2 With renal complications
0.000 0.817 0.183
E11.4 With neurological complications
0.000 0.820 0.180
N90.6 Hypertrophy of vulva
0.176 0.824 0.000
N41.9 Inflammatory disease of prostate, unspecified
0.174 0.826 0.000
E11.1 With ketoacidosis
0.000 0.827 0.173
L43.8 Other lichen planus
0.170 0.830 0.000
E11.6 With other specified complications
0.000 0.834 0.166
L43.3 Subacute (active) lichen planus
0.165 0.835 0.000
L43.2 Lichenoid drug reaction
0.165 0.835 0.000
L43.1 Bullous lichen planus
0.165 0.835 0.000
L43.0 Hypertrophic lichen planus
0.165 0.835 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.001 0.839 0.161
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.840 0.159
D05.7 Other carcinoma in situ of breast
0.146 0.854 0.000
N90.5 Atrophy of vulva
0.137 0.863 0.000
N50 Other disorders of male genital organs
0.135 0.865 0.000
K63.3 Ulcer of intestine
0.129 0.871 0.000
E24 Cushing's syndrome
0.004 0.872 0.125
N30.9 Cystitis, unspecified
0.126 0.874 0.000
E13.9 Without complications
0.001 0.875 0.123
E70-E90 Metabolic disorders
0.000 0.885 0.115
E83.1 Disorders of iron metabolism
0.000 0.891 0.109
D05.0 Lobular carcinoma in situ
0.107 0.893 0.000
E83 Disorders of mineral metabolism
0.000 0.894 0.106
E87 Other disorders of fluid, electrolyte and acid-base balance
0.000 0.904 0.096

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.